Practice
Featured experience
Bristol Myers Squibb $13 billion notes offering
The investment-grade offering comprised nine tranches
Cisco Systems $13.5 billion notes offering
The investment-grade offering comprises seven tranches of notes
Galderma Group CHF2.3 billion ($2.6 billion) IPO
We advised Galderma on its IPO
Novartis $3.7 billion notes offering
We advised Novartis on the investment-grade debt offering
Gamida Cell $23 million follow-on offering
The shares are listed on the Nasdaq Global Select Market
Enovix $162.5 million convertible senior notes and capped call transactions
The 3.00% convertible notes are due 2028
China Education Group CNY500 million CGIF-guaranteed bonds offering
The 4% bonds are due 2026
Canadian Pacific Railway $3 billion exchange offers and consent solicitations
The exchange offers and consent solicitations are for senior notes
Valaris $700 million senior secured second-lien notes offering
The high-yield senior secured second-lien notes are due 2030
Banco Santander Chile $30 million senior fixed-rate notes offering
We advised the issuer on the investment-grade notes offering
AN2 Therapeutics $100 million at-the-market offering
The shares are listed on the Nasdaq Global Select Market
AVITA Medical at-the-market offering
The stock is listed on the Nasdaq Global Market
Beisen Holding HK$155 million IPO
We advised Beisen on its IPO and HKEX listing
Cleveland-Cliffs $750 million notes offering
The high-yield notes are due 2030